Overview
- Injective, which rallied about 25–30% on Friday, climbed above $9 as trading volume and buying activity increased.
- CEO Eric Chen met White House, SEC and CFTC officials in Washington to discuss tokenization and on‑chain finance.
- Injective Institutional Services holds SEC registration as a transfer agent and Gulf Labs has begun operating an institutional validator on Injective's chain.
- On-chain data show exchange supply falling from roughly 1.26 million to about 872,500 INJ and Injective highlights a high revenue-to-fully-diluted-value ratio that funds a monthly community buyback program.
- Traders are watching a sustained break above $9.50–$9.60 for bullish confirmation while proposed staked‑INJ investment products remain under SEC review and could affect institutional access to tokenized securities.